| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99202 |
Office or other outpatient visit for the evaluation and management of a new patient, straightforward |
7,556 |
7,537 |
$453K |
| 93306 |
Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete |
2,090 |
2,084 |
$210K |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
3,005 |
2,916 |
$187K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
3,451 |
3,238 |
$130K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
2,811 |
2,528 |
$128K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
1,962 |
1,670 |
$109K |
| 93970 |
|
1,357 |
1,348 |
$108K |
| 93925 |
|
1,239 |
1,228 |
$92K |
| 78452 |
Myocardial perfusion imaging, tomographic (SPECT); multiple studies at rest and/or stress |
470 |
468 |
$85K |
| 37229 |
|
17 |
17 |
$81K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
672 |
672 |
$66K |
| U0005 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 |
3,006 |
2,917 |
$62K |
| 93922 |
|
1,354 |
1,338 |
$55K |
| 36247 |
|
101 |
101 |
$53K |
| 93923 |
|
684 |
681 |
$50K |
| 36478 |
|
58 |
50 |
$48K |
| A9500 |
Technetium tc-99m sestamibi, diagnostic, per study dose |
459 |
456 |
$36K |
| 93015 |
|
868 |
846 |
$35K |
| 93880 |
|
582 |
579 |
$32K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
561 |
472 |
$22K |
| 93000 |
|
1,687 |
1,661 |
$15K |
| 36200 |
|
97 |
97 |
$15K |
| 36140 |
|
101 |
101 |
$12K |
| 75716 |
|
100 |
100 |
$8K |
| 75630 |
|
101 |
101 |
$8K |
| 93971 |
|
111 |
98 |
$7K |
| 93224 |
|
104 |
103 |
$6K |
| 86769 |
|
190 |
152 |
$6K |
| 99152 |
|
181 |
179 |
$5K |
| 93926 |
|
121 |
120 |
$4K |
| 99201 |
|
89 |
88 |
$3K |
| 75635 |
|
12 |
12 |
$3K |
| 99401 |
|
338 |
324 |
$3K |
| 99441 |
|
61 |
53 |
$1K |
| G2066 |
Interrogation device evaluation(s), (remote) up to 30 days; implantable cardiovascular physiologic monitor system, implantable loop recorder system, or subcutaneous cardiac rhythm monitor system, remote data acquisition(s), receipt of transmissions and technician review, technical support and distribution of results |
16 |
15 |
$942.90 |
| 99153 |
Mod sedat endo service >5yrs |
122 |
120 |
$692.71 |
| 99406 |
|
38 |
38 |
$284.57 |
| 93298 |
|
16 |
15 |
$224.86 |
| 99000 |
|
40 |
39 |
$4.49 |
| 36415 |
Collection of venous blood by venipuncture |
135 |
135 |
$0.00 |
| 1000F |
|
14 |
14 |
$0.00 |
| 3008F |
|
37 |
33 |
$0.00 |
| 4086F |
|
15 |
14 |
$0.00 |
| 1036F |
|
12 |
12 |
$0.00 |
| 3074F |
|
13 |
13 |
$0.00 |
| G8783 |
Normal blood pressure reading documented, follow-up not required |
20 |
20 |
$0.00 |
| 99408 |
|
196 |
170 |
$0.00 |
| 99080 |
|
91 |
71 |
$0.00 |
| 1159F |
|
15 |
15 |
$0.00 |
| G8417 |
Bmi is documented above normal parameters and a follow-up plan is documented |
26 |
24 |
$0.00 |
| G8427 |
Eligible clinician attests to documenting in the medical record they obtained, updated, or reviewed the patient's current medications |
36 |
31 |
$0.00 |
| 1160F |
|
16 |
16 |
$0.00 |
| 3078F |
|
13 |
13 |
$0.00 |